Concarlo Holdings
Stacy Blain is the co-founder, CSO, and CEO of Concarlo Holdings. Stacy was previously employed at SUNY Downstate Medical Center.
Stacy Blain has a Ph.D. in Molecular and Cellular Biology from Columbia University, a Bachelor's Degree in Molecular Biology from Princeton University, and a Postdoctoral Fellowship in Molecular Biology from Memorial Sloan-Kettering Cancer Center.
Some direct reports include Irina Jilishitz - Research Scientist, Lisamarie Casey - Co-Founder & COO, and Sean Larkin - Director of Finance & HR.
This person is not in any offices
Concarlo Holdings
Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1.